Health Catalyst (NASDAQ:HCAT) Earns Buy Rating from Analysts at SunTrust Banks
SunTrust Banks started coverage on shares of Health Catalyst (NASDAQ:HCAT) in a research note issued to investors on Monday, BenzingaRatingsTable reports. The firm issued a buy rating and a $53.00 price target on the stock.
Separately, Evercore ISI started coverage on shares of Health Catalyst in a research report on Monday. They set an outperform rating and a $50.00 price target on the stock. Eight equities research analysts have rated the stock with a buy rating, The company presently has an average rating of Buy and an average price target of $51.29.
Shares of NASDAQ:HCAT opened at $43.66 on Monday. Health Catalyst has a 52 week low of $36.29 and a 52 week high of $49.85.
Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.
Read More: Equity Income
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.